in

Quiet!! Big Pharma Won’t Tout The Cancer Treating Power Of Ivermectin Because At $1 Per Dose, It Produces Little Revenue

As we’ve seen with COVID, pharmaceutical companies only care about lining their pockets and with the average cancer patient being worth $160,000, Ivermectin is off their radar

Credit: The Covid Blog

From TheCovidBlog.com…

We know that SARS-CoV-2 is a man-made “paravirus” if you will created Wuhan/Moderna laboratories and reinforced by mainstream media propaganda. But in the grand scheme, at least the first iteration released onto the world, so-called COVID-19 is a lightweight illness that is mostly just rebranded influenza.

The mRNA and viral vector injections, along with Remdesivir, combine for a quick two-year, $200 billion global racket for big pharma and Bill Gates. Ivermectin is a proven, powerful drug to treat and prevent so-called COVID-19, according to 108 peer-reviewed studies.

 

The Ivermectin Merck patents are long expired. So the cheap, $1-per-dose, Nobel Prize-winning drug poses a serious threat not only to the emergency use authorizations for the lethal injections, but also to the temporary COVID-19 racket. But those simply cannot be the only reasons for the persistent, petulant, childish mainstream media anti-Ivermectin propaganda.

 

 

Read More

Leave a Reply

Loading…

Video: A Bird Decides To Take A ‘Sh*t’ On Biden During Speech In Iowa

NY Lt. Gov. Brian Benjamin Arrested On Campaign Finance Fraud Charges